Trammell Crow Company delivers first phase of Georgia Tech district devoted to advancing sciences that improve the human condition

Exercise is good for you. To understand why, MoTrPAC scientists are creating a whole-body map of molecular responses to endurance training — finding striking “all tissue effects” in a new set of studies, featured on the May cover of the journal Nature.

First phase of innovation district promises to encourage medical advances, drive economic growth, and inspire future generations

Han will investigate whether blocking specific neurons can help inhibit asthma — which may provide a new avenue for developing treatments.

Using artificial intelligence, the team is developing an edible vaccine that could protect birds from bird flu and reduce its spread to livestock and humans.

Georgia Tech researchers demonstrated the mechanics behind neural tube closure, which can lead to severe or fatal birth defects if unsuccessful.

AI and machine learning provide new tools for scientists to think about drug discovery.

Housley and his team are developing self‑assembling nanohydrogels that deliver cancer drugs only when they reach tumor‑specific conditions, aiming to reduce side effects and make treatment more precise across multiple cancer types.

When Postdoctoral Research Fellow Hannah Youngblood’s work on exfoliation glaucoma (XFG) was featured by the BrightFocus Foundation, it caught the attention of Jennifer Rucker, an Alabama resident who was diagnosed with XFG several years ago.

Faculty at Georgia Tech use their expertise in engineering, math, and computer science to apply common principles of these disciplines to neuroscience research.